Non-Invasive Prenatal Testing (NIPT) is a new DNA-based blood test that measures the risk of trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome) with greater accuracy than traditional first trimester screening.
NIPT requires a single blood draw which poses no threat to the fetus, and can be done as early as 10 weeks gestation.
Please note: To comply with TGA requirements., we have limited the information in the public domain. Doctors are encouraged to vist Sonic Genetics to obtain the password.
Below is information for doctors and resources for your patients.
For centres able to perform NIPT collections, click the link.